Shionogi to Present New Fetroja®/Fetcroja® Data at IDWeek 2026 Highlighting Early Treatment Outcomes and Activity Against Drug-Resistant Gram-Negative Bacteria Shionogi & Co., Ltd., headquartered in Osaka, Japan, and led by…
Savillex Completes Acquisition of Entegris Life Sciences Fluid Management Business to Expand Single-Use Bioprocessing Portfolio Savillex, LLC, a leading provider of high-purity fluid handling solutions for life sciences and laboratory…
Cosette Pharmaceuticals Receives FDA Approval for EVOXAC® Oral Solution to Treat Dry Mouth in Adults With Sjögren’s Disease Cosette Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, has announced that the…
Bionyra Pharma Reports Positive Interim Phase 1 Results for Long-Acting Anti-TL1A Antibody BYN-002 Bionyra Pharma, a clinical-stage biopharmaceutical company developing next-generation biologics designed to harness multi-targeted biology for immune-mediated inflammatory…
Parse Biosciences Launches Evercode MAX to Expand Single-Cell Sequencing Capacity and Reduce Research Costs Parse Biosciences, a leading provider of scalable and accessible single-cell sequencing technologies and a QIAGEN company,…
Algia Pharma Completes IND-Enabling Toxicology Study for AlgiaPak, Advancing Non-Opioid Acute Pain Treatment Toward Clinical Trials Algia Pharma, LLC has announced the successful completion of an Investigational New Drug (IND)-enabling…
Johnson & Johnson Launches Shockwave C2 Aero Fly Coronary IVL Catheter to Cut Treatment Time in Half Johnson & Johnson (NYSE: JNJ) has announced the U.S. launch of its Shockwave…
Orogen Therapeutics Selects ORO-110 and ORO-210 Development Candidates for Inflammatory Diseases Orogen Therapeutics, Inc. (“Orogen” or the “Company”) announced the selection of two development candidates, ORO-110 and ORO-210, as potential…
Neurogene to Present New NGN-401 Gene Therapy Data for Rett Syndrome at ESGCT 2026 Neurogene Inc., a clinical-stage biotechnology company focused on developing genetic medicines for rare neurological diseases, announced…
New Research Uncovers Immune Mechanism Driving Radiation-Induced Lung Injury Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States,…
Roquette to Showcase Advanced Pharmaceutical Excipients and Drug Delivery Innovations at AAPS PharmSci 360 2026 Roquette, a global leader in plant-based ingredients, pharmaceutical excipients and specialized pharmaceutical solutions, will present…
BeOne Medicines Advances Solid Tumor Oncology Pipeline With New Data Across Breast, Lung and Gastrointestinal Cancers at ESMO 2026 BeOne Medicines Ltd., a global oncology company, announced that it will…